Tag: Relevium Technologies Inc.

October 9, 2019

Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada

Relevium is pleased to announce today that it has registered 400 Natural Product Numbers with Health Canada through its main...
September 19, 2019

Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix

Relevium Technologies Inc. announces its intention to create a new, publicly-traded company through a spin-out of Biocannabix Health Corporation.
June 13, 2019

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a...
June 11, 2019

Relevium Closes Private Placement Financing

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it...
June 3, 2019

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s...
May 30, 2019

Relevium Acquires Exclusive Licence From California Based Cannakids®

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix...
May 21, 2019

Relevium Announces Private Share Purchase by CEO

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), announced today that Mr. Aurelio Useche, Chief Executive Officer, has agreed...